Principal Human Viral Diseases: Present Status of Vaccination

Bektimirov, T. A.; Assaad, Fakhry A.

doi:10.1016/b978-0-12-429601-5.50015-0

Applied Virology 1984

DOI: 10.1016/b978-0-12-429601-5.50015-0

|View full text |Cite

Principal Human Viral Diseases: Present Status of Vaccination

T. A. Bektimirov¹,

Fakhry A. Assaad

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2004

2008

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to the modern experience, about 6 months are required for the creation, safety verification, and distribution in sufficient amounts of a new vaccine effective against a new influenza virus strain, which makes timely vaccination under the conditions of epidemic development a difficult task. In addition, vaccination is not as effective and safe in adults and patients with immune system disorders [8,9].…”

mentioning

confidence: 96%

Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)

Ленева¹,

Глушков²,

Gus'kova

2004

Pharm Chem J

View full text Add to dashboard Cite

mentioning

confidence: 96%

Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)

Ленева¹,

Глушков²,

Gus'kova

2004

Pharm Chem J

View full text Add to dashboard Cite

“…The fact that vaccine prophylactics is the most effective method of preventing influenza in the population is now beyond doubts [1]. The majority of live and inactivated vaccines are prepared on developing chick embryos (DCE).…”

mentioning

confidence: 99%

Comparative Analysis of Reproduction of Influenza Virus Strains in Cell Lines Perspective for the Creation of Cultural Vaccines Grown on Nutrient Medium on the Basis of Rise Flour Protein Hydrolysate

et al. 2008

View full text Add to dashboard Cite

We studied vaccine strains of influenza viruses A and B during their culturing in MDCK and Vero cells grown in Eagle's MEM medium and in a medium on the basis of enzyme hydrolysate of rise flour proteins with reduced (2%) content of fetal calf serum. Optimal conditions for cell culturing and reproduction of influenza virus strains in these cells were studied. Culturing of vaccine strains of influenza viruses in MDCK and Vero cells grown in nutrient media on the basis of rise flour protein hydrolysate yielded high infection titers, which suggests that this medium can be used for the development of cultural influenza vaccine.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Principal Human Viral Diseases: Present Status of Vaccination

Cited by 2 publications

References 14 publications

Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)

Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)

Comparative Analysis of Reproduction of Influenza Virus Strains in Cell Lines Perspective for the Creation of Cultural Vaccines Grown on Nutrient Medium on the Basis of Rise Flour Protein Hydrolysate

Contact Info

Product

Resources

About